ClinicalTrials.gov
ClinicalTrials.gov Menu

Study to Evaluate the Effects of Sorafenib if Combined With Chemotherapy (FOLFOX6 or FOLFIRI) in the Second-Line Treatment of Colorectal Cancer (FOSCO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00889343
Recruitment Status : Terminated
First Posted : April 28, 2009
Last Update Posted : March 4, 2013
Sponsor:
Information provided by (Responsible Party):
AIO-Studien-gGmbH

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : November 2011
  Actual Study Completion Date : December 2012